UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Use of expandable stents in the esophagus

Authors
Todd H Baron, MD
Ryan Law, DO
Section Editor
John R Saltzman, MD, FACP, FACG, FASGE, AGAF
Deputy Editor
Kristen M Robson, MD, MBA, FACG

INTRODUCTION

Expandable metal stents are now commonly used as a nonsurgical alternative for the palliation of luminal gastrointestinal neoplasms, particularly esophageal cancer [1]. Esophageal cancer is often diagnosed at an advanced stage, and stents can be useful for symptom palliation in patients with locally unresectable or advanced metastatic esophageal cancer, those with poor functional status who cannot tolerate surgery or chemoradiotherapy, or for those with locally recurrent disease after primary treatment. These patients generally have weight loss and dysphagia due to esophageal obstruction. Furthermore, cough and/or aspiration may be the result of a tracheoesophageal fistula, either as a complication of the tumor or its treatment.

Although less effective than when used for the treatment of distal esophageal obstruction, expandable metal stents can be placed successfully in patients with proximal or cervical esophageal malignant strictures [2]. Smaller diameter stents (tracheobronchial, biliary) may be better tolerated [3-5].

Esophageal stents may provide palliation of dysphagia caused by extraesophageal malignancies that compress the esophagus extrinsically. However, symptom improvement is significantly less in this setting than in patients with intrinsic esophageal lesions [6]. In addition, self-expandable stents are being used to treat benign esophageal disorders such as esophageal leaks, fistulas, and refractory strictures [7].

Additionally, esophageal stents are being increasingly used to treat benign esophageal diseases. Since nearly all stents are only approved for treatment of malignant disease, their use for benign disease is off-label.

This topic will review the use of expandable stents in the treatment of esophageal obstruction from esophageal cancer and extrinsic esophageal compression from extraesophageal malignancies. A general overview of several methods of endoscopic palliation for esophageal cancer and the use of expandable stents in other portions of the gastrointestinal tract are discussed elsewhere. (See "Endoscopic palliation of esophageal cancer" and "Enteral stents for the palliation of malignant gastroduodenal obstruction" and "Enteral stents for the management of malignant colorectal obstruction" and "Endoscopic stenting for malignant pancreaticobiliary obstruction".)

                       

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Dec 2016. | This topic last updated: Thu Dec 15 00:00:00 GMT 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Kochar R, Shah N. Enteral stents: from esophagus to colon. Gastrointest Endosc 2013; 78:913.
  2. Bethge N, Sommer A, Vakil N. A prospective trial of self-expanding metal stents in the palliation of malignant esophageal strictures near the upper esophageal sphincter. Gastrointest Endosc 1997; 45:300.
  3. Battaglia G, Antonello A, Realdon S, et al. Feasibility, efficacy and safety of stent insertion as a palliative treatment for malignant strictures in the cervical segment of the esophagus and the hypopharynx. Surg Endosc 2016; 30:159.
  4. Speer E, Dunst CM, Shada A, et al. Covered stents in cervical anastomoses following esophagectomy. Surg Endosc 2016; 30:3297.
  5. Bechtler M, Wagner F, Fuchs ES, Jakobs R. Biliary metal stents for proximal esophageal or hypopharyngeal strictures. Surg Endosc 2015; 29:3205.
  6. Bethge N, Sommer A, Vakil N. Palliation of malignant esophageal obstruction due to intrinsic and extrinsic lesions with expandable metal stents. Am J Gastroenterol 1998; 93:1829.
  7. Sharma P, Kozarek R, Practice Parameters Committee of American College of Gastroenterology. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 2010; 105:258.
  8. DaVee T, Irani S, Leggett CL, et al. Stent-in-stent technique for removal of embedded partially covered self-expanding metal stents. Surg Endosc 2016; 30:2332.
  9. Dormann AJ, Eisendrath P, Wigginghaus B, et al. Palliation of esophageal carcinoma with a new self-expanding plastic stent. Endoscopy 2003; 35:207.
  10. Decker P, Lippler J, Decker D, Hirner A. Use of the Polyflex stent in the palliative therapy of esophageal carcinoma: results in 14 cases and review of the literature. Surg Endosc 2001; 15:1444.
  11. Bethge N, Vakil N. A prospective trial of a new self-expanding plastic stent for malignant esophageal obstruction. Am J Gastroenterol 2001; 96:1350.
  12. Costamagna G, Shah SK, Tringali A, et al. Prospective evaluation of a new self-expanding plastic stent for inoperable esophageal strictures. Surg Endosc 2003; 17:891.
  13. Fuccio L, Hassan C, Frazzoni L, et al. Clinical outcomes following stent placement in refractory benign esophageal stricture: a systematic review and meta-analysis. Endoscopy 2016; 48:141.
  14. Conio M, Repici A, Battaglia G, et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol 2007; 102:2667.
  15. Verschuur EM, Repici A, Kuipers EJ, et al. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 2008; 103:304.
  16. Adler DG, Fang J, Wong R, et al. Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapy. Gastrointest Endosc 2009; 70:614.
  17. Siddiqui AA, Glynn C, Loren D, Kowalski T. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study. Dis Esophagus 2009; 22:216.
  18. Bower M, Jones W, Vessels B, et al. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy. Ann Surg Oncol 2009; 16:3161.
  19. Brown RE, Abbas AE, Ellis S, et al. A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety. J Am Coll Surg 2011; 212:582.
  20. Hirdes MM, Siersema PD, van Boeckel PG, Vleggaar FP. Single and sequential biodegradable stent placement for refractory benign esophageal strictures: a prospective follow-up study. Endoscopy 2012; 44:649.
  21. Hirdes MM, van Hooft JE, Wijrdeman HK, et al. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer. Gastrointest Endosc 2012; 76:267.
  22. Canena JM, Liberato MJ, Rio-Tinto RA, et al. A comparison of the temporary placement of 3 different self-expanding stents for the treatment of refractory benign esophageal strictures: a prospective multicentre study. BMC Gastroenterol 2012; 12:70.
  23. ASGE Technology Committee, Tokar JL, Banerjee S, et al. Drug-eluting/biodegradable stents. Gastrointest Endosc 2011; 74:954.
  24. van Boeckel PG, Vleggaar FP, Siersema PD. A comparison of temporary self-expanding plastic and biodegradable stents for refractory benign esophageal strictures. Clin Gastroenterol Hepatol 2011; 9:653.
  25. van Hooft JE, van Berge Henegouwen MI, Rauws EA, et al. Endoscopic treatment of benign anastomotic esophagogastric strictures with a biodegradable stent. Gastrointest Endosc 2011; 73:1043.
  26. Repici A, Vleggaar FP, Hassan C, et al. Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study. Gastrointest Endosc 2010; 72:927.
  27. Stivaros SM, Williams LR, Senger C, et al. Woven polydioxanone biodegradable stents: a new treatment option for benign and malignant oesophageal strictures. Eur Radiol 2010; 20:1069.
  28. Fujii LL, Bonin EA, Baron TH, et al. Utility of an endoscopic suturing system for prevention of covered luminal stent migration in the upper GI tract. Gastrointest Endosc 2013; 78:787.
  29. Irani S, Baron TH, Gluck M, et al. Preventing migration of fully covered esophageal stents with an over-the-scope clip device (with videos). Gastrointest Endosc 2014; 79:844.
  30. Sharaiha RZ, Kumta NA, Doukides TP, et al. Esophageal Stenting With Sutures: Time to Redefine Our Standards? J Clin Gastroenterol 2015; 49:e57.
  31. Mudumbi S, Velazquez-Aviña J, Neumann H, et al. Anchoring of self-expanding metal stents using the over-the-scope clip, and a technique for subsequent removal. Endoscopy 2014; 46:1106.
  32. Jacobson BC, Hirota W, Baron TH, et al. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc 2003; 57:817.
  33. Acunaş B, Rozanes I, Akpinar S, et al. Palliation of malignant esophageal strictures with self-expanding nitinol stents: drawbacks and complications. Radiology 1996; 199:648.
  34. Saxon RR, Morrison KE, Lakin PC, et al. Malignant esophageal obstruction and esophagorespiratory fistula: palliation with a polyethylene-covered Z-stent. Radiology 1997; 202:349.
  35. Ell C, May A, Hahn EG. Gianturco-Z stents in the palliative treatment of malignant esophageal obstruction and esophagotracheal fistulas. Endoscopy 1995; 27:495.
  36. Winkelbauer FW, Schöfl R, Niederle B, et al. Palliative treatment of obstructing esophageal cancer with nitinol stents: value, safety, and long-term results. AJR Am J Roentgenol 1996; 166:79.
  37. Rozanes I, Poyanli A, Acunaş B. Palliative treatment of inoperable malignant esophageal strictures with metal stents: one center's experience with four different stents. Eur J Radiol 2002; 43:196.
  38. Siersema PD, Hop WC, van Blankenstein M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001; 54:145.
  39. Philips P, North DA, Scoggins C, et al. Gastric-Esophageal Stenting for Malignant Dysphagia: Results of Prospective Clinical Trial Evaluation of Long-Term Gastroesophageal Reflux and Quality of Life-Related Symptoms. J Am Coll Surg 2015; 221:165.
  40. Raijman I, Siddique I, Ajani J, Lynch P. Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc 1998; 48:172.
  41. Morgan RA, Ellul JP, Denton ER, et al. Malignant esophageal fistulas and perforations: management with plastic-covered metallic endoprostheses. Radiology 1997; 204:527.
  42. Verschuur EM, Kuipers EJ, Siersema PD. Esophageal stents for malignant strictures close to the upper esophageal sphincter. Gastrointest Endosc 2007; 66:1082.
  43. Im JP, Kang JM, Kim SG, et al. Clinical outcomes and patency of self-expanding metal stents in patients with malignant upper gastrointestinal obstruction. Dig Dis Sci 2008; 53:938.
  44. Dai Y, Li C, Xie Y, et al. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev 2014; :CD005048.
  45. Amdal CD, Jacobsen AB, Sandstad B, et al. Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial. Radiother Oncol 2013; 107:428.
  46. Touchefeu Y, Archambeaud I, Landi B, et al. Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer. Dig Liver Dis 2014; 46:283.
  47. Battersby NJ, Bonney GK, Subar D, et al. Outcomes following oesophageal stent insertion for palliation of malignant strictures: A large single centre series. J Surg Oncol 2012; 105:60.
  48. Kim ES, Jeon SW, Park SY, et al. Comparison of double-layered and covered Niti-S stents for palliation of malignant dysphagia. J Gastroenterol Hepatol 2009; 24:114.
  49. Siddiqui AA, Sarkar A, Beltz S, et al. Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy. Gastrointest Endosc 2012; 76:44.
  50. van den Berg MW, Walter D, de Vries EM, et al. Biodegradable stent placement before neoadjuvant chemoradiotherapy as a bridge to surgery in patients with locally advanced esophageal cancer. Gastrointest Endosc 2014; 80:908.
  51. Mariette C, Gronnier C, Duhamel A, et al. Self-expanding covered metallic stent as a bridge to surgery in esophageal cancer: impact on oncologic outcomes. J Am Coll Surg 2015; 220:287.
  52. Mão-de-Ferro S, Serrano M, Ferreira S, et al. Stents in patients with esophageal cancer before chemoradiotherapy: high risk of complications and no impact on the nutritional status. Eur J Clin Nutr 2016; 70:409.
  53. Van Heel NC, Haringsma J, Spaander MC, et al. Esophageal stents for the palliation of malignant dysphagia and fistula recurrence after esophagectomy. Gastrointest Endosc 2010; 72:249.
  54. van Heel NC, Haringsma J, Spaander MC, et al. Esophageal stents for the relief of malignant dysphagia due to extrinsic compression. Endoscopy 2010; 42:536.
  55. Rhee K, Kim JH, Jung DH, et al. Self-expandable metal stents for malignant esophageal obstruction: a comparative study between extrinsic and intrinsic compression. Dis Esophagus 2016; 29:224.
  56. Rodrigues-Pinto E, Pereira P, Ribeiro A, et al. Self-expanding metal stents in postoperative esophageal leaks. Rev Esp Enferm Dig 2016; 108:133.
  57. Licht E, Markowitz AJ, Bains MS, et al. Endoscopic Management of Esophageal Anastomotic Leaks After Surgery for Malignant Disease. Ann Thorac Surg 2016; 101:301.
  58. Freeman RK, Ascioti AJ, Dake M, Mahidhara RS. An Assessment of the Optimal Time for Removal of Esophageal Stents Used in the Treatment of an Esophageal Anastomotic Leak or Perforation. Ann Thorac Surg 2015; 100:422.
  59. Gonzalez JM, Garces Duran R, Vanbiervliet G, et al. Double-type metallic stents efficacy for the management of post-operative fistulas, leakages, and perforations of the upper gastrointestinal tract. Surg Endosc 2015; 29:2013.
  60. van den Berg MW, Kerbert AC, van Soest EJ, et al. Safety and efficacy of a fully covered large-diameter self-expanding metal stent for the treatment of upper gastrointestinal perforations, anastomotic leaks, and fistula. Dis Esophagus 2016; 29:572.
  61. Dasari BV, Neely D, Kennedy A, et al. The role of esophageal stents in the management of esophageal anastomotic leaks and benign esophageal perforations. Ann Surg 2014; 259:852.
  62. Hoeppner J, Kulemann B, Seifert G, et al. Covered self-expanding stent treatment for anastomotic leakage: outcomes in esophagogastric and esophagojejunal anastomoses. Surg Endosc 2014; 28:1703.
  63. El Hajj II, Imperiale TF, Rex DK, et al. Treatment of esophageal leaks, fistulae, and perforations with temporary stents: evaluation of efficacy, adverse events, and factors associated with successful outcomes. Gastrointest Endosc 2014; 79:589.
  64. McCarty TR, Njei B. Self-expanding metal stents for acute refractory esophageal variceal bleeding: A systematic review and meta-analysis. Dig Endosc 2016; 28:539.
  65. Schubert D, Scheidbach H, Kuhn R, et al. Endoscopic treatment of thoracic esophageal anastomotic leaks by using silicone-covered, self-expanding polyester stents. Gastrointest Endosc 2005; 61:891.
  66. Langer FB, Wenzl E, Prager G, et al. Management of postoperative esophageal leaks with the Polyflex self-expanding covered plastic stent. Ann Thorac Surg 2005; 79:398.
  67. Hünerbein M, Stroszczynski C, Moesta KT, Schlag PM. Treatment of thoracic anastomotic leaks after esophagectomy with self-expanding plastic stents. Ann Surg 2004; 240:801.
  68. Gelbmann CM, Ratiu NL, Rath HC, et al. Use of self-expandable plastic stents for the treatment of esophageal perforations and symptomatic anastomotic leaks. Endoscopy 2004; 36:695.
  69. Aiolfi A, Bona D, Ceriani C, et al. Stent-in-stent, a safe and effective technique to remove fully embedded esophageal metal stents: case series and literature review. Endosc Int Open 2015; 3:E296.
  70. Fiocca F, Cereatti F, Antypas P, Donatelli G. Argon plasma coagulation: a less-expensive alternative to the "stent-in-stent" technique for removal of embedded partially covered esophageal stents. Gastrointest Endosc 2016; 83:453.
  71. Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 2001; 344:1681.
  72. Baron TH. Minimizing endoscopic complications: endoluminal stents. Gastrointest Endosc Clin N Am 2007; 17:83.
  73. Hendra KP, Saukkonen JJ. Erosion of the right mainstem bronchus by an esophageal stent. Chest 1996; 110:857.
  74. Fuccio L, Scagliarini M, Frazzoni L, Battaglia G. Development of a prediction model of adverse events after stent placement for esophageal cancer. Gastrointest Endosc 2016; 83:746.
  75. Ramirez FC, Dennert B, Zierer ST, Sanowski RA. Esophageal self-expandable metallic stents--indications, practice, techniques, and complications: results of a national survey. Gastrointest Endosc 1997; 45:360.
  76. Kinsman KJ, DeGregorio BT, Katon RM, et al. Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy. Gastrointest Endosc 1996; 43:196.
  77. Siersema PD, Hop WC, Dees J, et al. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 1998; 47:113.
  78. Sumiyoshi T, Gotoda T, Muro K, et al. Morbidity and mortality after self-expandable metallic stent placement in patients with progressive or recurrent esophageal cancer after chemoradiotherapy. Gastrointest Endosc 2003; 57:882.
  79. Nishimura Y, Nagata K, Katano S, et al. Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal Diseases. Int J Radiat Oncol Biol Phys 2003; 56:1327.
  80. Lecleire S, Di Fiore F, Ben-Soussan E, et al. Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer. Aliment Pharmacol Ther 2006; 23:1693.
  81. Park JY, Shin JH, Song HY, et al. Airway complications after covered stent placement for malignant esophageal stricture: special reference to radiation therapy. AJR Am J Roentgenol 2012; 198:453.
  82. Bick BL, Song LM, Buttar NS, et al. Stent-associated esophagorespiratory fistulas: incidence and risk factors. Gastrointest Endosc 2013; 77:181.
  83. Ludwig D, Dehne A, Burmester E, et al. Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy. Int J Oncol 1998; 13:583.
  84. May A, Hahn EG, Ell C. Self-expanding metal stents for palliation of malignant obstruction in the upper gastrointestinal tract. Comparative assessment of three stent types implemented in 96 implantations. J Clin Gastroenterol 1996; 22:261.
  85. Lagattolla NR, Rowe PH, Anderson H, Dunk AA. Restenting malignant oesophageal strictures. Br J Surg 1998; 85:261.
  86. Laquière A, Grandval P, Heresbach D, et al. Self-expanding plastic stent removed after radiochemotherapy for advanced esophageal cancer. Dis Esophagus 2014; 27:176.